Effect of Dapagliflozin on VT in Patients With Heart Failure.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05550441
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT05550441
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05550441. Randomized; quadruple masking; primary purpose treatment. Start 2022-11-15 (anticipated); primary completion 2024-11-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Dapagliflozin on VT in Patients With Heart Failure.
- Condition
- Heart Failure
- Intervention (Drug)
- Dapagliflozin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct05550441- Content hash
ef8897eb6e3b1b0fef448733eb1d89b222b81c6e868a8aa459b79a1173076a8c